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Abstract Three new halimane-type diterpenoids formosins A–C (1–3), and three clerodane-type diterpenoids formosins
D–F (4–6), were isolated from the twigs of Excoecaria formosana. Their structures were assigned on the basis of
spectroscopic data analysis. Compounds 1 and 4 showed moderate anti-microbial activities against Bacillus subtilis
(MIC = 50 and 50 lg/mL, respectively). Compound 6 exhibited moderate anti-microbial activities against two strains of
Helicobacter pylori (Hp-SS1 and ATCC 43504) with MIC values of 50 and 50 lg/mL, respectively.
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1 Introduction
The genus Excoecaria (Euphorbiaceae) compromising 40
species, are widely distributed in Africa and East Asia [1].
Several plants in this genus have been used in folk medicine
to treat psoriasis, dermatitis and pruritus [2–4]. The charac-
teristic of this plant genus is the poisonous milk latex, which
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genus have led to the isolation of structurally diverse com-
pounds with significant biological activities including anti-
tumor promoting, anti-ulcer, and anti-microbial activities
[6–10]. In the current study, three new halimane-type diter-
penoids formosins A–C (1–3), and three clerodane-type
diterpenoids formosins D–F (4–6), were isolated from the
twigs of Excoecaria formosana. Presented herein are the
isolation, structural characterization, and biological evalua-
tion of these compounds.
2 Results and Discussion
Compound 1, a white powder, gave a molecular formula
C20H28O3 as determined by the (?)-HRESIMS ion at m/z
339.1937 [M ? Na]? (calcd 339.1931) requiring seven
degrees of unsaturation. The IR absorptions (3000–
2800 cm-1, broad band) and (1695 cm-1) showed the
presence of a carboxylic group. The diagnostic NMR data
(Tables 1, 2) suggested the presence of a b-substituted furan
ring (dH 6.27, 7.22, and 7.34), a persubstituted double bond,
and a carboxylic group (dC 181.5). These functionalities
accounted for five out of the seven indices of hydrogen
deficiency, requiring the presence of two additional rings in
the structure of 1. The aforementioned data suggested that
compound 1 is a halimane-type diterpenoid and is struc-
turally related to crotohalimaneic acid [11]. The planar
structure of 1 was deduced by 2D NMR spectra. In the
HMBC spectrum (Fig. 1), two tertiary methyls (dH 1.00, and
1.04, each 3H, s) correlating with C-3, C-4 and C-5 were
attached to C-4. The multiple HMBC correlations of H-3,
H-7, and H3-19/C-5 (dC 141.3); H-1, H-8, and H-11/C-10 (dC
125.2); and H3-17/C-7, C-8, and C-9 indicated the presence
of a typical D5(10) double bond and 8-Me (C-17). The b-
substituted furan ring and carboxylic group were located at
C-12 and C-9 by the HMBC correlations of H-12/C-13, C-14
and C-16; and H-8 and H-11/C-20, respectively. The relative
configuration of 1 was established by the ROESY experi-
ment (Fig. 1). The ROESY cross-peaks of H3-18/H-2b,
H-2b/H-1b, H-1b/H-11, and H-12/H-8 indicated that they
are co-facial and randomly assigned in a b-configuration. In
consequence, H3-19 and H3-17 were a-oriented by the
ROESY correlations of H3-19/H-6a and H3-17/H-7a. The
structure of 1 (formosin A) was herein elucidated as shown.
Table 1 1H NMR data for compounds 1–6 in CDCl3 at 400 MHz
Position 1 (mult., J in Hz) 2 (mult., J in Hz) 3 (mult., J in Hz) 4 (mult., J in Hz) 5 (mult., J in Hz) 6 (mult., J in Hz)
1 a 1.92 (m) a 1.86 (m) a 1.90 (m) a 1.76 (m) a 1.67 (m) a 2.89 (dd, 17.9, 14.5)
b 1.68 (m) b 1.64 (m) b 1.68 (m) b 2.22 (m) b 2.32 (m) b 2.66 (dd, 17.9, 3.1)
2 1.64 (m) 1.60 (m) 1.60 (m) 3.61 (m) 4.19 (m)
3 a 1.36 (td, 12.5,
5.4)
a 1.35 (td, 12.1,
4.3)
a 1.36 (m) 5.43 (d, 4.7) 5.27 (br s) 5.78 (s)
b 1.50 (m) b 1.46 (m) b 1.52 (m)
6 a 2.12 (m) a 2.12 (m) a 2.16 (m) a 1.79 (m) a 1.80 (m) a 2.16 (m)
b 1.94 (m) b 1.92 (m) b 1.94 (m) b 1.29 (m) b 1.21 (m) b 1.40 (m)
7 a 1.52 (m) a 1.52 (m) a 1.56 (m) a 2.11 (m) a 2.11 (m) a 2.24 (m)
b 1.70 (m) b 1.66 (m) b 1.72 (m) b 1.47 (m) b 1.47 (m) b 1.56 (m)
8 1.78 (m) 1.73 (m) 1.75 (m) 1.61 (m) 1.55 (m) 1.62 (m)
10 1.95 (m) 1.62 (m) 1.90 (m)














2.34 (m) 2.33 (m)
14 6.27 (br s) 7.17 (t, 1.6) 6.83 (br s) 6.28 (br s) 6.28 (br s) 6.26 (br s)
15 7.34 (br s) 4.77 (d, 1.8) 5.74 (br s) 7.34 (br s) 7.35 (br s) 7.34 (br s)
16 7.22 (br s) 7.22 (br s) 7.23 (br s) 7.22 (br s)
17 0.95 (d, 6.7) 0.94 (d, 6.7) 0.94 (d, 5.6) 1.16 (d, 6.8) 1.15 (d, 6.9) 1.17 (d, 6.8)
18 1.04 (s) 1.04 (s) 1.03 (s) 1.65 (s) 1.62 (s) 1.90 (s)
19 1.00 (s) 1.00 (s) 0.99 (s) 0.91 (s) 0.99 (s) 1.08 (s)
2-OMe 3.34 (s)
15-OMe 3.49 (s)
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Compound 2 had the molecular formula of C20H28O4, as
determined by the 13C NMR data and the (?)-HRESIMS
ion at m/z 355.1839 [M ? Na]? (calcd 355.1880), which is
16 mass units more than that of 1. Comparison of its NMR
spectroscopic data (Tables 1, 2) with those of 1 revealed
they are structural analogues with the obvious difference
being the presence of an a,b-unsaturated-c-lactone moiety
instead of the b-substituted furan ring. It was confirmed by
the NMR data (dH 4.77 and 7.17; dC 70.2, 134.5, 143.9, and
174.3), as well as the key HMBC correlations from H-12 to
C-13, C-14, and C-16 (Figure S13, Supporting Informa-
tion). Thus, the structure of 2 (formosin B) was determined
as shown.
Compound 3 displayed a molecular formula of
C21H30O5 as established by the (?)-HRESIMS at m/z
385.1991 [M ? Na]? (calcd 385.1991) and the 13C NMR
data. Analysis of the NMR data (Tables 1, 2) of 3 showed
many similarities to those of 2. The only difference was the
presence of an additional methoxy group (dH 3.49, s, 3H),
which was located at C-15 to form the acetal motif, which
was confirmed by the downfield shifted C-15 (DdC 32.3) as
compared to that of 2. Compound 3 was obtained as a pair
of inseparable C-15 epimers, which exhibited several pairs
of very close carbon resonances in the 13C NMR spectrum
(Figure S19, Supplementary Material). Therefore, the
structure of 3 (formosin C) with its relative configuration
was confirmed as depicted by the HMBC and ROESY
spectra (Figures S21 and S22, Supplementary Material).
Compound 4 was obtained as a white powder with a
molecular formula of C21H30O4 as established by the
13C
NMR data and the (?)-HRESIMS ion at m/z 369.1970
[M ? Na]? (calcd 369.2036), demanding seven degrees of
unsaturation. The IR absorption bands (3000–2800 cm-1,
broad band; and 1695 cm-1) showed the presence of a
carboxylic group. The characteristic NMR signals for a b-
furan ring, a trisubstituted double bond, a methoxyl and a
carboxylic groups were observed from the 1H and 13C
NMR spectroscopic data analysis (Tables 1, 2). Compre-
hensive analysis of the NMR spectra of 4 revealed its
structure is highly related with that of junceic acid [12]
with a clerodane-type diterpenoid backbone. The only
difference was the presence of an additional methoxyl
group in 4, which was placed at C-2 by the HMBC cor-
relation (Fig. 2) from CH3O (dH 3.34) to C-2 (dC 74.3).
The carboxylic group was attached to C-9 via the HMBC
correlations from H-8, H-10 and H-11 to C-20 (dC 182.6).
The key HMBC cross-peaks from H3-18 to C-3 (dC 120.6),
C-4 (dC 149.2) and C-5, and from H3-19 to C-4 revealed
the presence of D3 double bond. The relative configuration
of 4 was established by the ROESY experiment (Fig. 2).
The ROESY correlations of H-10/H-6b and H-10/H-8
indicated that H-8 and H-10 are co-facial and randomly
Table 2 13C NMR data for compounds 1–6 in CDCl3 at 100 MHz
Carbons 1 2 3 4 5 6
1 19.5 19.4 19.4 24.6 30.7 36.5
2 28.2 28.0 28.1 74.3 69.4 199.9
3 39.4 39.3 39.3 120.6 125.1 125.8
4 34.8 34.8 34.8 149.2 146.5 171.4
5 141.3 141.7 142.2 39.3 39.2 40.2
6 25.1 25.0 25.0 36.8 37.1 36.2
7 27.5 27.4 27.4 27.1 27.0 26.7
8 33.6 33.4 33.5 36.8 36.9 36.7
9 54.9 54.6 54.6 49.5 49.4 49.8
10 125.2 125.3 125.1 42.5 46.1 46.1
11 31.0 28.7 28.4 (28.5) 33.7 33.7 33.4
12 18.8 19.5 19.5 17.2 17.4 17.8
13 125.7 134.5 138.9 124.8 124.3 123.9
14 111.0 143.9 141.5 110.9 110.8 110.7
15 142.7 70.2 102.5 142.8 142.9 142.9
16 138.5 174.3 171.3 138.5 138.6 138.7
17 17.4 17.4 17.4 16.5 16.6 16.3
18 26.6 26.6 26.6 18.1 17.9 19.2
19 29.0 28.9 28.9 16.0 17.4 16.0


































































Fig. 2 a Selected HMBC, and b ROESY correlations of 4
Formosins A–F: Diterpenoids with Anti-microbial Activities from Excoecaria formosana 59
123
assigned in a b-configuration. Consequently, H3-19 and
H-2 were thus assigned to be a-directed by the ROESY
correlations of H3-19/H-1a, H3-19/H-7a, and H-2/H-1a.
Therefore, the structure of 4 (formosin D) was established
as depicted.
Compound 5 possessed a molecular formula C20H28O4
based on the 13C NMR data and the (?)-HRESIMS ion at
m/z 355.1885 [M ? Na]? (calcd 355.1888), which is 14
mass units less than that of 4. Detailed analysis of the NMR
data (Tables 1, 2) of 5 revealed that its structure is closely
related with that of 4 with the only difference being the
absence of the methyl etherification, which is consistent
with the molecular formula. The structure of 5 (formosin
E) with the relative configuration was further confirmed by
HMBC and ROESY spectra (Figures S39 and S40, Sup-
plementary Material).
Compound 6, named formosin F, exhibited a sodiated
molecular ion at m/z 353.1724 [M ? Na]? (calcd
353.1723) in the (?)-HRESIMS, consistent with a molec-
ular formula of C20H26O4, which was supported by the
13C
NMR data. Comparison of the NMR data (Tables 1, 2) of 6
with those of 5 revealed they are structural analogues. The
main difference was the presence of a keto group at C-2 in
6 instead of the hydroxy group in the latter, which was
confirmed by the HMBC correlations (Figure S42, Sup-
porting Information) from H-3 and H-10 to C-2 (dC 199.9).
The structure of 6 was thus determined as shown.
The new isolates were tested for anti-microbial activities
against a panel of microbes in vitro by the microdilution
method [13, 14]. Compounds 1 and 4 exhibited moderate
activity against Bacillus subtilis ATCC 6633 with MIC
values of 50 and 50 lg/mL, respectively, where magnolol
was used as the positive control (MIC = 12.5 lg/mL).
Compound 6 showed moderate antibacterial activities
against two strains Helicobacter pylori (Hp-SS1 or ATCC
43504) with MIC values of 50 and 50 lg/mL, respectively,
and metronidazole was used as the positive control
(MIC = 0.312 and 128 lg/mL, respectively).
3 Experimental Section
3.1 General Experimental Procedures
Optical rotations were determined on a Perkin-Elmer 341
polarimeter. UV spectra were recorded on a Shimadzu UV-
2550 spectrophotometer. IR spectra were acquired on a
Perkin-Elmer 577 spectrometer. NMR spectra were mea-
sured on a Bruker AM-400 spectrometer with TMS as
internal standard. ESIMS and HRESIMS were performed
on a Bruker Daltonics Esquire 3000 plus and a Waters-
Micromass Q-TQF Ultima Global mass spectrometer,
respectively. Semi-preparative HPLC was performed on a
Waters 1525 binary pump system with a Waters 2489
detector (210 nm) and equipped with a YMC-Pack ODS-A
(250 9 10 mm, S-5 lm). Silica gel (200–300 mesh,
Qingdao Haiyang Chemical Co., Ltd.), C18 reversed-phase
(RP-18) silica gel (20–45 lm, Fuji Silysia Chemical Ltd.),
CHP20P MCI gel (75–150 lm, Mitsubishi Chemical Cor-
poration), and Sephadex LH-20 gel (Amersham Bio-
sciences) were used for column chromatography (CC). Pre-
coated silica gel GF254 plates (Qingdao Haiyang Chemical
Co., Ltd.) were used for TLC detection. All solvents used
for CC were of analytical grade (Shanghai Chemical
Reagents Co., Ltd.), and solvents used for HPLC were of
HPLC grade (J & K Scientific Ltd.).
3.2 Plant Material
The twigs of E. formosanawere collected from Sanya city of
Hainan Province, the People’s Republic of China, and
authenticated by Prof. S.-M. Huang, Department of Biology,
Hainan University. A voucher specimen has been deposited
in Shanghai Institute of Materia Medica, Chinese Academy
of Sciences (accession number: SMEF-2006-1Y).
3.3 Extraction and Isolation
The air-dried, powdered twigs of E. formosana (6.0 kg)
was extracted three times with 95 % EtOH at room tem-
perature to give a crude extract (290 g), which was parti-
tioned between EtOAc and H2O. The EtOAc-soluble
fraction (85 g) was subjected to passage over an MCI gel
column (MeOH/H2O, 3:7–9:1) to afford fractions A–G.
Fraction C (25.7 g) was separated over a silica gel column
eluted with gradient mixtures of petroleum ether–acetone
(35:1–1:1, v/v) to afford major fractions C1-C6. Fraction
C3 (3.4 g) was separated on a reversed-phase C18 silica gel
column (MeOH/H2O, 55–100 %) to yield three major
portions (C3a–C3c), and each of those was purified by a
semi-preparative HPLC (60 % CH3CN in H2O, 3 mL/min)
to yield compounds 1 (20 mg), 2 (10 mg), and 6 (100 mg),
respectively. Fraction C4 (515 mg) was purified by a semi-
preparative HPLC (55 % CH3CN in H2O, 3 mL/min) to
give compound 4 (15 mg). Fraction C6 (1.5 g) was sepa-
rated on a column of Sephadex LH-20, and then purified by
a semi-preparative HPLC (50 % CH3CN in H2O, 3 mL/
min) to yield compound 5 (8 mg). Fraction E (11.4 g) was
chromatographed on a silica gel column eluted with pet-
roleum ether-ethyl acetate (25:1–1:4, v/v) to afford sub-
fractions E1–E4. Fraction E2 (217 mg) was separated on a
reversed-phase column containing C18 silica gel (MeOH/
H2O, 70–100%) to yield three fractions E2a–E2c. Fraction
E2b (35 mg) was separated by a semi-preparative HPLC
(70 % CH3CN in H2O, 3 mL/min) to yield compound 3
(8 mg).
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3.4 Formosin A (1)
White powder; ½a21D ?123 (c 0.10, MeOH); UV (MeOH)
kmax (log e) 206 (4.19) nm; IR (KBr) mmax 3444,
3000–2500, 1695, 1622, 1458, 1257, 1024, 600 cm-1; 1H
NMR (CDCl3), see Table 1 and
13C NMR (CDCl3) see
Table 2; (?)-ESIMS m/z 339.2 [M ? Na]?; (?)-HRE-
SIMS m/z 339.1937 [M ? Na]? (calcd for C20H28O3Na,
339.1931).
3.5 Formosin B (2)
White powder; ½a21D ?212 (c 0.10, MeOH); UV (MeOH)
kmax (log e) 207 (3.92); IR (KBr) mmax 3435, 3000–2500,
1753, 1695, 1456, 1205, 1070, 756 cm-1; 1H NMR
(CDCl3), see Table 1 and
13C NMR (CDCl3) see Table 2;
(?)-ESIMS m/z 355.2 [M ? Na]?; (?)-HRESIMS m/z
355.1839 [M ? Na]? (calcd for C20H28O4Na, 355.1880).
3.6 Formosin C (3)
White powder; ½a21D ?22 (c 0.10, MeOH); UV (MeOH)
kmax (log e) 211 (3.58); IR (KBr) mmax 3425, 3000–2500,
1726, 1693, 1659, 1468, 1178, 1065, 600 cm-1; 1H NMR
(CDCl3), see Table 1 and
13C NMR (CDCl3) see Table 2;
(?)-ESIMS m/z 385.2 [M ? Na]?; (?)-HRESIMS m/z
385.1991 [M ? Na]? (calcd for C21H30O5Na, 385.1991).
3.7 Formosin D (4)
White powder; ½a21D -164 (c 0.025, MeOH); UV (MeOH)
kmax (log e) 204 (4.21); IR (KBr) mmax 3427, 3000–2500,
1695, 1452, 1254, 1082 cm-1; 1H NMR (CDCl3), see
Table 1 and 13C NMR (CDCl3) see Table 2; (?)-ESIMS
m/z 369.2 [M ? Na]?; (?)-HRESIMS m/z 369.1970
[M ? Na]? (calcd for C21H30O4Na, 369.2036).
3.8 Formosin E (5)
White powder; ½a21D -20 (c 0.05, MeOH); UV (MeOH)
kmax (log e) 199 (3.89); IR (KBr) mmax 3419, 3000–2500,
1695, 1452, 1383, 1244, 1026, 874, 600 cm-1; 1H NMR
(CDCl3), see Table 1 and
13C NMR (CDCl3) see Table 2;
(?)-ESIMS m/z 355.2 [M ? Na]?; (?)-HRESIMS m/z
355.1885 [M ? Na]? (calcd for C20H28O4Na, 355.1888).
3.9 Formosin F (6)
White powder; ½a21D -175 (c 0.10, MeOH); UV (MeOH)
kmax (log e) 237 (4.86); IR (KBr) mmax 3000–2500, 1703,
1633, 1435, 1381, 1219, 1026, 874 cm-1; 1H NMR
(CDCl3), see Table 1 and
13C NMR (CDCl3) see Table 2;
(?)-ESIMS m/z 331 [M ? H]?; (?)-HRESIMS m/z
353.1724 [M ? Na]? (calcd for C20H26O4Na, 353.1723).
3.10 Antimicrobial Activity Assay
The in vitro antibacterial activities against Bacillus subtilis
ATCC 6633 were tested by applying the protocols descri-
bed in our previous research [13].
Antibacterial tests against Helicobacter pylori strains
(Hp-SS1 or ATCC 43504 strain) were carried out in vitro
according to the protocols described previously [14].
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